← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2011Last known activity
May 1, 2014
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT01961934Overall official - principal investigatorPhase 2/Phase 3May 1, 2014
- NCT01961934Lead sponsorPhase 2/Phase 3May 1, 2014
- NCT01961934Reponsible party - principal investigatorPhase 2/Phase 3May 1, 2014
- NCT01530269Reponsible party - principal investigatorPhase 2Apr 1, 2012
- NCT01530269Overall official - principal investigatorPhase 2Apr 1, 2012
- NCT01530269Lead sponsorPhase 2Apr 1, 2012
- NCT01304485Overall official - principal investigatorPhase 2Apr 1, 2011
- NCT01304485Lead sponsorPhase 2Apr 1, 2011
- NCT01304485Reponsible party - principal investigatorPhase 2Apr 1, 2011
Details
- Last known activity
- May 1, 2014